Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation

68Citations
Citations of this article
102Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BACKGROUND Patients treated with hematopoietic cell transplantation (HCT) often experience depression and fatigue but analyses to determine risk factors have typically lacked statistical power. The current study examined sociodemographic and clinical risk factors for depression and fatigue in a large cohort of survivors of HCT. METHODS Measures of depression and fatigue were included in an annual survey of HCT recipients that also included self-reported sociodemographic and health information. Patient clinical characteristics were obtained from the clinical database. RESULTS The sample consisted of 1869 recipients (with a mean age of 56 years; 53% male) who were a mean of 13 years (allogeneic recipients) and 6 years (autologous recipients) from HCT. Moderate to severe depression was reported by 13% of participants; moderate to severe fatigue was reported by 42%. Among allogeneic recipients, female sex, younger age, current presence of chronic pain, and current patient-reported severity of chronic graft-versus-host disease were found to be independently associated with greater depression whereas female sex, current presence of chronic pain, and current severity of chronic graft-versus-host disease were independently associated with greater fatigue (P values

Cite

CITATION STYLE

APA

Jim, H. S. L., Sutton, S. K., Jacobsen, P. B., Martin, P. J., Flowers, M. E., & Lee, S. J. (2016). Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation. Cancer, 122(8), 1290–1297. https://doi.org/10.1002/cncr.29877

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free